Sutinat 50 mg (Sunitinib)

Sutinat 50 mg contains Sunitinib, a targeted treatment for kidney cancer, GIST, and neuroendocrine tumors, used under oncologist supervision.

pack size Price Add to Cart
28 Tablets - USD $4.80 Per Tablet$134.40
View Cart
56 Tablets - USD $4.50 Per Tablet$252.00
View Cart
84 Tablets - USD $4.40 Per Tablet$369.60
View Cart

Sutinat 50 mg (Sunitinib)

Active IngredientSunitinib
Indication:Kidney Cancer and Gastrointestinal Stromal Tumor
Manufacturer:Natco Pharma Ltd.
Packaging28 capsules in 1 bottle
Strength50mg
Delivery Time6 To 15 days

Sutinat 50 mg contains Sunitinib, a targeted cancer therapy known as a tyrosine kinase inhibitor (TKI). It is primarily used in the treatment of advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors. Sunitinib works by blocking specific enzymes that promote cancer cell growth, division, and blood supply.

Sutinat 50 mg is prescribed under strict oncological supervision and is typically taken in treatment cycles (e.g., 4 weeks on, 2 weeks off). It offers targeted action with fewer effects on healthy cells compared to traditional chemotherapy. Regular monitoring is essential during therapy to manage side effects and evaluate response.

pack size

28 Tablets – USD $4.80 Per Tablet, 56 Tablets – USD $4.50 Per Tablet, 84 Tablets – USD $4.40 Per Tablet

There are no reviews yet.

Be the first to review “Sutinat 50 mg (Sunitinib)”